Mr. HAN Yuewei
Mr. HAN Yuewei, was appointed as an executive Director, chief executive officer of the Company in October 2019. He also serves as the chairman of Dong-E-E-Jiao Company Limited（东阿阿胶股份有限公司）(“Dong-E-E-Jiao”) (the shares of which are listed on the Shenzhen Stock Exchange, Stock Code: 000423), and a director of CR Sanjiu and a director of China Resources Double-Crane Pharmaceutical Company Limited（凯发k8一触即发双鹤药业股份有限公司）(“CR Double-Crane”) (the shares of which are listed on the Shanghai Stock Exchange, Stock Code: 600062). Mr. HAN served as an executive director of China Resources Medical Holdings Company Limited (“CR Medical”) (listed on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”), stock code: 1515) from October 2017 to October 2019, during which he served as the chief executive officer of CR Medical and the general manager of China Resources Healthcare Group Limited, the controlling shareholder of CR Medical. Mr. HAN worked for China Resources Land Limited (“CR Land”) (listed on the Stock Exchange, stock code: 1109) from October 2010 to October 2017, during which he served as deputy general manager of Shenyang Region, deputy general manager of Shenzhen Region, director of engineering and vice president of CR Land. Prior to joining CR Land, Mr. HAN worked as the deputy director and director of the Bureau of Public Works of Shenzhen Municipality（深圳市建筑工务署）from April 2002 to October 2010. Mr. HAN obtained a master’s degree in construction economics and management from Tsinghua University（清华大学）and a bachelor’s degree in construction management from Tsinghua University in July 1993 and July 1991 respectively.
